Barriers to Swiss guideline-recommended cholesterol management in general practice

Swiss Medical Weekly

Volumn 140, Issue 19-20, 2010, Pages 280-285

  Bally, Klaus ^a   Martina, Benedict ^a   Halter, Ursina ^a   Isler, Ruedi ^a   Tschudi, Peter ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Barriers; Dyslipidaemia; Guidelines; Management; Primary care

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRACTICE GUIDELINE; SECONDARY PREVENTION; SWITZERLAND;

EID: 77952385163     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad spectrum of initial cholesterol levels. The long-term intervention with pravastatin in ischemic disease (LIPID) study group. New Engl J Med. 1998;339:1349-1357
2. Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504
3. Graham I, Atar D, Borch-Johnsen K, et al. ESC Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis. 2007;194:1-45.
4. Schweizerische Gesellschaft für Kardiologie. Empfehlungen 1999 zur Behandlung des Risikofaktors Cholesterin. Schweiz Ärztezeitung. 1999;80:549-552
5. Goldberg RJ, Rosen J, Roselli A, Lewis B. Survey of physician's attitudes and practices toward lipid-lowering management strategies. Cardiology. 2007;107:302-306 (Pubitemid 46788248)
6. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from Euroaspire II Euro Heart Survey Programme. Eur Heart J. 2001;22:554-572
7. McBride P, Schrott HG, Plane MB, Underbakke G, Brown RL. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med. 1998;158:1238-1244 (Pubitemid 28252488)
8. Muntwyler J, Noseda G, Darioli R, Gruner C, Gutzwiller F, Follath F. Survey on prescription of cardiovascular drugs among outpatients with coronary artery disease in Switzerland. Swiss Med Wkly. 2003;133:88-92. (Pubitemid 36323619)
9. Euraspire I and II group; European Action on secondary prevention by intervention to reduce events. Clinical reality of coronary prevention guidelines. Lancet. 2001;357:995-1001.
10. Mehta RH, Bhatt DL, Steg PG, et al. REACH Registry Investigators. Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J. 2008;29:3052-3060
11. Erhardt LR. Barriers to effective implementation of guideline recommendations. Am J Med. 2005;118(Suppl 12A):36-41.
12. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19:596-604.
13. Mosca L, Linfante AH, Benjamin EJ, Berra K, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499-510.
14. Yan AT, Yan RT, Tan M, et al. Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators. Contemporary management of dyslipidemia in high-risk patients: targets still not met. Am J Med. 2006;119:676-683
15. Petrella RJ, Merikle E, Jones J. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis. Clin Ther. 2007;29:742-750
16. Steinhagen-Thiessen E, Bramlage P, Losch C, et al. Dyslipidemia in primary care - prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2008;7(1):31. Epub.
17. Journath G, Hellénius ML, Manhem K, Kjellgren KI, Nilsson PM; Hyper-Q Study Group, Sweden. Association of physician's sex with risk factor control in treated hypertensive patients from Swedish primary healthcare. J Hypertens. 2008;26:2050-2056
18. Kotseva K, Stagmo M, De Bacquer D, De Backer G, Wood D; on behalf of EUROASPIRE II Study Group. Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey. Atherosclerosis. 2008;197:710-717